WO2003062372A3 - Nanoparticle assembled hollow spheres - Google Patents

Nanoparticle assembled hollow spheres Download PDF

Info

Publication number
WO2003062372A3
WO2003062372A3 PCT/US2002/031446 US0231446W WO03062372A3 WO 2003062372 A3 WO2003062372 A3 WO 2003062372A3 US 0231446 W US0231446 W US 0231446W WO 03062372 A3 WO03062372 A3 WO 03062372A3
Authority
WO
WIPO (PCT)
Prior art keywords
nanoparticles
composition
hollow spheres
catalysis
spheres
Prior art date
Application number
PCT/US2002/031446
Other languages
French (fr)
Other versions
WO2003062372A2 (en
Inventor
Jennifer Cha
Timothy J Deming
Galen D Stucky
Michael Wong
Henrik Birkedal
Michael H Bartl
Jan L Sumerel
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Priority to AU2002365255A priority Critical patent/AU2002365255A1/en
Publication of WO2003062372A2 publication Critical patent/WO2003062372A2/en
Publication of WO2003062372A3 publication Critical patent/WO2003062372A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/701—Integrated with dissimilar structures on a common substrate
    • Y10S977/702—Integrated with dissimilar structures on a common substrate having biological material component
    • Y10S977/705—Protein or peptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/249921—Web or sheet containing structurally defined element or component
    • Y10T428/249994—Composite having a component wherein a constituent is liquid or is contained within preformed walls [e.g., impregnant-filled, previously void containing component, etc.]
    • Y10T428/249995—Constituent is in liquid form
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Abstract

A design strategy for constructing hierarchically structured materials using nanoparticles and synthetic biopolymers has been developed. Block copolypeptides or homopolymer polyelectrolytes are used as structure-directing agents to arrange nanoparticles (composed of metals, metal non-oxides, metal oxides, or organics) into unusual microstructures, such as spheres, “apples” and “cups”. Hollow spheres can be made wherein nanoparticles of one composition are spatially oriented completely interior or exterior to nanoparticles of a second composition. These aggregates contain nanoparticles only in the shell walls, and maintain their hollowness upon calcination. These shapes can also be fabricated into films. These robust materials are anticipated to have great promise in applications that require surface catalysis, magnetic/electronic/optic properties, transport capabilities, and combinations thereof, such as drug delivery, packaging, catalysis, and sensors.
PCT/US2002/031446 2001-10-02 2002-10-02 Nanoparticle assembled hollow spheres WO2003062372A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002365255A AU2002365255A1 (en) 2001-10-02 2002-10-02 Nanoparticle assembled hollow spheres

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32687001P 2001-10-02 2001-10-02
US60/326,870 2001-10-02
US36093902P 2002-03-01 2002-03-01
US60/360,939 2002-03-01

Publications (2)

Publication Number Publication Date
WO2003062372A2 WO2003062372A2 (en) 2003-07-31
WO2003062372A3 true WO2003062372A3 (en) 2004-03-04

Family

ID=27616631

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/031446 WO2003062372A2 (en) 2001-10-02 2002-10-02 Nanoparticle assembled hollow spheres

Country Status (3)

Country Link
US (1) US7563457B2 (en)
AU (1) AU2002365255A1 (en)
WO (1) WO2003062372A2 (en)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7683098B2 (en) 1996-09-03 2010-03-23 Ppg Industries Ohio, Inc. Manufacturing methods for nanomaterial dispersions and products thereof
AU2003299478A1 (en) 2002-05-07 2004-05-25 Regents Of The University Of California Bioactivation of particles
US7176036B2 (en) 2002-09-20 2007-02-13 Arrowhead Center, Inc. Electroactive microspheres and methods
US8409618B2 (en) 2002-12-20 2013-04-02 Kimberly-Clark Worldwide, Inc. Odor-reducing quinone compounds
US7666410B2 (en) 2002-12-20 2010-02-23 Kimberly-Clark Worldwide, Inc. Delivery system for functional compounds
US7444045B2 (en) * 2003-10-14 2008-10-28 3M Innovative Properties Company Hybrid sphere-waveguide resonators
US7259855B2 (en) * 2003-10-14 2007-08-21 3M Innovative Properties Company Porous microsphere resonators
US7879350B2 (en) 2003-10-16 2011-02-01 Kimberly-Clark Worldwide, Inc. Method for reducing odor using colloidal nanoparticles
US7488520B2 (en) * 2003-10-16 2009-02-10 Kimberly-Clark Worldwide, Inc. High surface area material blends for odor reduction, articles utilizing such blends and methods of using same
US7754197B2 (en) 2003-10-16 2010-07-13 Kimberly-Clark Worldwide, Inc. Method for reducing odor using coordinated polydentate compounds
US7837663B2 (en) * 2003-10-16 2010-11-23 Kimberly-Clark Worldwide, Inc. Odor controlling article including a visual indicating device for monitoring odor absorption
US7438875B2 (en) 2003-10-16 2008-10-21 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified silica particles
US7582485B2 (en) * 2003-10-16 2009-09-01 Kimberly-Clark Worldride, Inc. Method and device for detecting ammonia odors and helicobacter pylori urease infection
US7794737B2 (en) 2003-10-16 2010-09-14 Kimberly-Clark Worldwide, Inc. Odor absorbing extrudates
US7413550B2 (en) * 2003-10-16 2008-08-19 Kimberly-Clark Worldwide, Inc. Visual indicating device for bad breath
US7678367B2 (en) 2003-10-16 2010-03-16 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified particles
CA2558916C (en) * 2003-10-20 2009-09-22 William Marsh Rice University Method to fabricate microcapsules from polymers and charged nanoparticles
AU2004285553B2 (en) * 2003-10-31 2009-12-10 Teva Pharmaceutical Industries, Ltd. Nanoparticles for drug delivery
US7790473B2 (en) * 2003-11-05 2010-09-07 The United States Of America As Represented By The Department Of Health And Human Services Biofunctionalized quantum dots for biological imaging
US20070275007A1 (en) * 2003-11-05 2007-11-29 The Government Of The United States Of America, Represented By The Secretary Of Health And Human S Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof as Antimetastatic Agents in Treating Cancer
US7565920B2 (en) * 2003-11-07 2009-07-28 The Hong Kong Polytechnic University Woven fabric with moisture management properties
US20050101209A1 (en) * 2003-11-07 2005-05-12 The Hong Kong Polytechnic University Woven fabric with moisture management properties
US20050152955A1 (en) * 2003-12-16 2005-07-14 Akhave Jay R. Electrostatically self-assembled antimicrobial coating for medical applications
TWI388876B (en) * 2003-12-26 2013-03-11 Fujifilm Corp Antireflection film, polarizing plate, method for producing them, liquid crystal display element, liquid crystal display device, and image display device
EP1711211A1 (en) * 2004-01-15 2006-10-18 Koninklijke Philips Electronics N.V. Ultrasound contrast agents for molecular imaging
US7972437B2 (en) * 2004-03-22 2011-07-05 The Regents Of The University Of California Hollow nanocrystals and method of making
US20050220714A1 (en) * 2004-04-01 2005-10-06 Susan Kauzlarich Agents for use in magnetic resonance and optical imaging
EP1743174B1 (en) * 2004-04-20 2013-03-20 Emory University Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
US7271379B2 (en) * 2004-05-27 2007-09-18 3M Innovative Properties Company Dielectric microcavity fluorosensors excited with a broadband light source
US7352933B2 (en) * 2004-05-27 2008-04-01 3M Innovative Properties Company Dielectric microcavity sensors
US20050265935A1 (en) * 2004-05-28 2005-12-01 Hollingsworth Jennifer A Semiconductor nanocrystal quantum dots and metallic nanocrystals as UV blockers and colorants for suncreens and/or sunless tanning compositions
WO2006093516A2 (en) * 2004-06-22 2006-09-08 The Regents Of The University Of California Peptide-coated nanoparticles with graded shell compositions
US7229690B2 (en) * 2004-07-26 2007-06-12 Massachusetts Institute Of Technology Microspheres including nanoparticles
US20060083694A1 (en) 2004-08-07 2006-04-20 Cabot Corporation Multi-component particles comprising inorganic nanoparticles distributed in an organic matrix and processes for making and using same
WO2006029302A2 (en) * 2004-09-09 2006-03-16 Applera Corporation Dioxetane-nanoparticle assemblies for energy transfer detection systems, methods of making the assemblies, and methods of using the assemblies in bioassays
US7257279B2 (en) * 2004-09-20 2007-08-14 3M Innovative Properties Company Systems and methods for biosensing and microresonator sensors for same
CA2520670A1 (en) * 2004-09-23 2006-03-23 National Research Council Of Canada Nanocrystal coated surfaces
US7722951B2 (en) * 2004-10-15 2010-05-25 Georgia Tech Research Corporation Insulator coating and method for forming same
EP1824521B1 (en) * 2004-11-19 2015-01-07 Koninklijke Philips N.V. Ultrasound contrast agents for molecular imaging
WO2006061835A1 (en) * 2004-12-07 2006-06-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Spherical composites entrapping nanoparticles, processes of preparing same and uses thereof
JP4928775B2 (en) * 2005-01-06 2012-05-09 株式会社日立ソリューションズ Semiconductor nanoparticle surface modification method
US8007829B2 (en) * 2005-01-19 2011-08-30 William Marsh Rice University Method to fabricate inhomogeneous particles
US7964380B2 (en) * 2005-01-21 2011-06-21 Argylia Technologies Nanoparticles for manipulation of biopolymers and methods of thereof
WO2007002690A2 (en) 2005-06-24 2007-01-04 William Marsh Rice University Nano-encapsulated triggered-release viscosity breakers
CA2616404A1 (en) * 2005-07-26 2007-02-01 Oregon Health & Science University Nanoparticle probes for capture, sorting and placement of targets
WO2007021621A2 (en) * 2005-08-09 2007-02-22 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College In vivo imaging and therapy with magnetic nanoparticle conjugates
US20070037215A1 (en) * 2005-08-11 2007-02-15 Patton Wayne F Assay particles and methods of use
US20100222501A1 (en) * 2005-08-11 2010-09-02 Wm. Marsh Rice University Scalable process for synthesizing uniformly-sized composite nanoparticles
WO2007041569A1 (en) * 2005-09-30 2007-04-12 Ilypsa, Inc. Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
AU2006301847B2 (en) 2005-10-14 2011-11-17 Vive Nano Inc. Composite nanoparticles, nanoparticles and methods for producing same
AU2006330627A1 (en) 2005-12-16 2007-07-05 University Of Kansas Nanoclusters for delivery of therapeutics
US20090011222A1 (en) * 2006-03-27 2009-01-08 Georgia Tech Research Corporation Superhydrophobic surface and method for forming same
US7389025B2 (en) * 2006-03-29 2008-06-17 3M Innovative Properties Company Coupling light into microresonators
US7532790B2 (en) * 2006-03-29 2009-05-12 3M Innovative Properties Company Method of coupling light into microresonators
US7670679B2 (en) * 2006-05-30 2010-03-02 General Electric Company Core-shell ceramic particulate and method of making
US20100258759A1 (en) * 2006-06-06 2010-10-14 Cornell Research Foundation, Inc. Nanostructured Metal Oxides Comprising Internal Voids and Methods of Use Thereof
WO2008033804A2 (en) * 2006-09-11 2008-03-20 The Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University Quantum dot barcode structures and uses thereof
EP1903337B1 (en) * 2006-09-20 2015-07-22 Mycartis N.V. Coating for microcarriers
US7744673B2 (en) * 2006-10-27 2010-06-29 Stc.Unm Hollow sphere metal oxides
US20080119927A1 (en) * 2006-11-17 2008-05-22 Medtronic Vascular, Inc. Stent Coating Including Therapeutic Biodegradable Glass, and Method of Making
US20120138862A1 (en) * 2007-01-16 2012-06-07 Genvault Corporation Nanoparticles useful for biomolecule storage
AU2008213911A1 (en) * 2007-02-09 2008-08-14 Newsouth Innovations Pty Limited Hollow microparticles
US20080193766A1 (en) * 2007-02-13 2008-08-14 Northern Nanotechnologies Control of Transport to and from Nanoparticle Surfaces
WO2009064964A2 (en) * 2007-11-15 2009-05-22 The University Of California Switchable nano-vehicle delivery systems, and methods for making and using them
US20090163887A1 (en) * 2007-12-20 2009-06-25 Arehart Kelly D Odor control cellulose granules with quinone compounds
WO2009145813A1 (en) * 2008-03-04 2009-12-03 Qd Vision, Inc. Particles including nanoparticles, uses thereof, and methods
US20090252988A1 (en) * 2008-04-04 2009-10-08 Honeywell International Inc. Coated components for use in high temperature environments and methods of forming a coating on the component
WO2009129537A2 (en) * 2008-04-18 2009-10-22 Gary Zabow Magnetic microstructures for magnetic resonance imaging
US20090291214A1 (en) * 2008-05-23 2009-11-26 Battelle Memorial Institute Protein inks of colloidal immobilized proteins
US20130023714A1 (en) * 2008-10-26 2013-01-24 Board Of Regents, The University Of Texas Systems Medical and Imaging Nanoclusters
US8093177B2 (en) * 2008-11-06 2012-01-10 Wisconsin Alumni Research Foundation Metal oxides having molecular and/or biomolecular functionalization
EP2387787B1 (en) 2008-12-19 2018-09-12 Ferronova Pty Ltd Magnetic nanoparticles
US8062555B2 (en) * 2009-04-16 2011-11-22 Rhodia Operations Co-assembly method and co-assembled structures made thereby
WO2011031876A1 (en) 2009-09-09 2011-03-17 Qd Vision, Inc. Formulations including nanoparticles
KR101865888B1 (en) 2009-09-09 2018-06-08 삼성전자주식회사 Particles including nanoparticles, uses thereof, and methods
US9803060B2 (en) * 2009-09-10 2017-10-31 Bridgestone Corporation Compositions and method for making hollow nanoparticles from metal soaps
US20110085968A1 (en) * 2009-10-13 2011-04-14 The Regents Of The University Of California Articles comprising nano-materials for geometry-guided stem cell differentiation and enhanced bone growth
US8211744B2 (en) * 2009-11-20 2012-07-03 Electronics And Telecommunications Research Institute Methods of forming nano structure and methods of forming solar cell using the same
US8288001B1 (en) 2010-02-16 2012-10-16 Sandia Corporation Method of making monodisperse nanoparticles
US20130295012A1 (en) 2010-08-30 2013-11-07 President And Fellows Of Harvard College Shear controlled release for stenotic lesions and thrombolytic therapies
TWI398495B (en) * 2010-09-14 2013-06-11 Univ Nat Taiwan Science Tech Method of manufacturing anti-counterfeit ink and anti-counterfeit tag and method of manufacturing the same
CN102019431B (en) * 2010-09-30 2013-06-05 大连理工大学 Metallic nano cluster/silicon dioxide hollow nuclear shell structured nanoparticles and preparation method thereof
CN102274725A (en) * 2011-05-05 2011-12-14 大连理工大学 Efficient nanometer gold-base catalytic hydrogenation catalyst and preparation method thereof
CN102352106B (en) * 2011-07-15 2013-04-10 中国科学院化学研究所 Organic polymer-silica nanocomposite material and its preparation method
EP2758036A2 (en) * 2011-09-21 2014-07-30 Yissum Research and Development Company of The Hebrew University of Jerusalem Nano delivery systems
US9267889B1 (en) * 2011-10-12 2016-02-23 Stc.Unm High efficiency light absorbing and light emitting nanostructures
KR101444424B1 (en) * 2011-10-14 2014-09-29 한국생명공학연구원 Method for Preparing Multi-functional Biomolecular Conjugates Using Two Kinds of Particle and Multi-functional Biomolecular Conjugates Prepared Therefrom
US20150299758A1 (en) * 2011-11-08 2015-10-22 Kanagawa Academy Of Science And Technology Magnetic nanoparticles
US10752526B2 (en) 2012-02-12 2020-08-25 Bluflow Technologies, Inc. Method for destruction of reducible contaminants in waste or ground water
US8940655B2 (en) * 2012-02-20 2015-01-27 University Of Maryland, College Park Porous oxide microparticles and composites thereof and methods of making and using same
US10217540B2 (en) * 2012-03-28 2019-02-26 Massachusetts Institute Of Technology Multifunctional nanoparticles
WO2013158744A2 (en) * 2012-04-17 2013-10-24 Cerion Enterprises, Llc Nanoparticles of cerium and amino acids
DK2861212T3 (en) 2012-06-13 2017-03-06 Cerion Llc Cerium oxide nanoparticles for the treatment of oxidative stress
CN102909007B (en) * 2012-07-19 2015-01-21 上海师范大学 Catalyst with core-shell structure, and preparation method and application thereof
CN104870575B (en) * 2012-12-20 2018-03-09 3M创新有限公司 Anti-soil wear-resisting structure and preparation method thereof
US9334200B2 (en) 2013-01-28 2016-05-10 Bfp Management, Llc Fertilizer composition and method for suspending fertilizer in an aqueous solution
US10060851B2 (en) 2013-03-05 2018-08-28 Plexense, Inc. Surface plasmon detection apparatuses and methods
CN103163095A (en) * 2013-03-25 2013-06-19 江南大学 Visual multifunctional detection method based on nano-silver
KR101592241B1 (en) 2013-04-15 2016-02-05 (주)플렉센스 Method of fabricating a device having an array of nano particles, surface plasmon based sensor, and method of assaying substances using the sensor
US9675953B2 (en) * 2013-10-09 2017-06-13 Nanocomposix, Inc. Encapsulated particles
JP2017502950A (en) 2013-12-11 2017-01-26 ユニバーシティー オブ マサチューセッツＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｍａｓｓａｃｈｕｓｅｔｔｓ Compositions and methods for treating diseases using Salmonella T3SS effector protein (SipA)
CN106659802B (en) * 2014-06-13 2021-06-25 加利福尼亚大学董事会 Nanostructured carriers for guided and targeted on-demand substance delivery
CN107249758A (en) * 2014-12-15 2017-10-13 福莱森斯有限公司 Surface plasma detection means and method
WO2016100723A1 (en) * 2014-12-18 2016-06-23 The Regents Of The University Of California Nanoparticle capsules for photonic crystal color display in magnetic field
CN104623693B (en) * 2015-01-21 2017-02-22 北京科技大学 Preparation method of fluorescent nano-composite having drug-release function
WO2016140860A2 (en) * 2015-02-25 2016-09-09 The Trustees Of Columbia University In The City Of New York Peptide linker for attachment of thiol-reactive molecules to surfaces
US10843139B2 (en) 2016-06-28 2020-11-24 The Trustees Of The University Of Pennsylvania Superoleophobic membranes for oil/water separation
KR20200083643A (en) * 2016-08-10 2020-07-08 고꾸리쯔다이가꾸호오진 구마모또 다이가꾸 Nanoparticle assemblies and method for producing nanoparticle assemblies
WO2018218052A1 (en) * 2017-05-24 2018-11-29 Northwestern University Nanoparticle-lipid composite carriers and uses thereof
US10894756B2 (en) 2017-07-13 2021-01-19 Tianjin University Method for catalytically hydrogenating oxalates
KR101960616B1 (en) * 2017-09-28 2019-03-21 (주)바이오스퀘어 Highly sensitive biomolecule detection method based on multiple quantum dots
BR112020007408A2 (en) 2017-10-31 2020-10-13 Rohm And Haas Company multi-stage colored polymeric particle for use in a skin care formulation, skin care formulation, and method for treating a selected area of skin.
WO2020016876A1 (en) * 2018-07-16 2020-01-23 Nanoscent Ltd. Sensing element for chemiresistor sensor and method of making same
US11298430B2 (en) 2018-10-01 2022-04-12 Northwestern University Magnetic nanocomposite compositions
CN113549445B (en) * 2020-04-23 2023-04-18 中国科学院化学研究所 Organic thermal activation delayed fluorescence micro-cavity laser and preparation method and application thereof
EP4221685A1 (en) 2020-09-29 2023-08-09 Oxford University Innovation Limited Stroke treatment
US11357620B1 (en) * 2021-09-10 2022-06-14 California LASIK & Eye, Inc. Exchangeable optics and therapeutics
CN114272373B (en) * 2021-12-29 2023-02-28 济南大学 Near-infrared light-controlled Au @ Cu/H-CeO2@ BSA-Cy5 nano motor and preparation method and application thereof
WO2023242848A1 (en) * 2022-06-14 2023-12-21 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Institute) Superhydrophobic coatings

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840340A (en) * 1992-06-15 1998-11-24 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US6123965A (en) * 1996-01-26 2000-09-26 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US6395029B1 (en) * 1999-01-19 2002-05-28 The Children's Hospital Of Philadelphia Sustained delivery of polyionic bioactive agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285819A (en) * 1980-01-28 1981-08-25 California Institute Of Technology Functional magnetic microspheres
US4861627A (en) * 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
DE19730125A1 (en) * 1997-07-14 1999-01-21 Basf Ag Solid surface containing alumina
EP1064088B1 (en) * 1998-03-19 2002-12-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates
US6497729B1 (en) * 1998-11-20 2002-12-24 The University Of Connecticut Implant coating for control of tissue/implant interactions
AU2002246587A1 (en) * 2000-11-03 2002-08-06 Wm. Marsh Rice University Partial coverage metal nanoshells and method of making same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840340A (en) * 1992-06-15 1998-11-24 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US6123965A (en) * 1996-01-26 2000-09-26 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US6395029B1 (en) * 1999-01-19 2002-05-28 The Children's Hospital Of Philadelphia Sustained delivery of polyionic bioactive agents

Also Published As

Publication number Publication date
WO2003062372A2 (en) 2003-07-31
AU2002365255A1 (en) 2003-09-02
US20030082237A1 (en) 2003-05-01
US7563457B2 (en) 2009-07-21

Similar Documents

Publication Publication Date Title
WO2003062372A3 (en) Nanoparticle assembled hollow spheres
Kharissova et al. Greener synthesis of chemical compounds and materials
Guo et al. Cold sintering: progress, challenges, and future opportunities
He et al. Hydrodynamically Driven Self‐Assembly of Giant Vesicles of Metal Nanoparticles for Remote‐Controlled Release
Sukhorukov et al. Intelligent micro-and nanocapsules
EP1775226A3 (en) Load-carrying apparatus and methods of manufacture
GB0103754D0 (en) Three-dimensional structured printing
ATE401100T1 (en) ABSORBENT ITEMS WITH METAL-LOADED NANOPARTICLES
HUP0402392A2 (en) Container for a flowable product, process of manufacture and the use thereof
WO2008045101A3 (en) Ordered nanoenergetic composites and synthesis method
WO2004031732A3 (en) Nanocrystals in ligand boxes exhibiting enhanced chemical, photochemical, and thermal stability, and methods of making the same
ATE450484T1 (en) COMPOSITE MATERIAL AND METHOD FOR PRODUCING IT
Wang et al. Self-propelling hydrogel/emulsion-hydrogel soft motors for water purification
WO2003059817A3 (en) Nano composite materials with enhanced properties
JP2011093291A (en) Earthen plastic composite product and method of manufacturing the same
German Sintering
WO2001016047A3 (en) Composite ceramic having nano-scale grain dimensions and method for manufacturing same
JP2005219791A (en) Supporting member for packing drive shaft for vehicle
JP2006315701A (en) Liquid jetting nozzle and packaging bag using the same
IT1321014B1 (en) CONTAINER TRANSPORT SYSTEM, PARTICULARLY SUITABLE FOR THE USE OF A PLANT FOR THE PRODUCTION OF PAINTS, PAINTS AND
KR20180024094A (en) Multilayer film comprising nano composite and method for producing the same
WO2000073154A3 (en) Multi-shell device for storing and transporting chemicals
Kamiya Recent function improvement and applicability of particulate materials.
CN203827645U (en) Ceramic outer shell device
CA2381752A1 (en) Collapsible article carrier and blank

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP